L Fiume

Summary

Affiliation: University of Bologna
Country: Italy

Publications

  1. ncbi Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine
    Luigi Fiume
    Department of Experimental Pathology, University of Bologna, Via San Giacomo, 14 40126 Bologna, Italy
    J Hepatol 43:645-52. 2005
  2. ncbi Lactosaminated human albumin, a hepatotropic carrier of drugs
    Luigi Fiume
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, I 40126 Bologna, Italy
    Eur J Pharm Sci 40:253-62. 2010
  3. ncbi Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug
    Luigi Fiume
    Department of Experimental Pathology, University of Bologna, Italy
    Drug Discov Today 13:1002-9. 2008
  4. ncbi The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow
    L Fiume
    Department of Experimental Pathology, University of Bologna, Italy
    Eur J Pharm Biopharm 72:630-1. 2009
  5. ncbi Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy
    Dig Liver Dis 38:404-8. 2006
  6. ncbi Coupling of 5-fluoro 2'-deoxyuridine to lactosaminated poly-l-lysine: an approach to a regional, non-invasive chemotherapy of liver micrometastases
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, 40126, Bologna, Italy
    Biochem Pharmacol 61:459-65. 2001
  7. ncbi Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Bologna, Italy
    Dig Liver Dis 40:278-84. 2008
  8. ncbi Floxuridine coupling with lactosaminated human albumin to increase drug efficacy on liver micrometastases
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Italy
    Dig Liver Dis 34:439-46. 2002
  9. ncbi Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy
    Dig Liver Dis 35:428-33. 2003
  10. ncbi Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin
    L Fiume
    Department of Experimental Pathology, University of Bologna, Italy
    Lancet 2:13-5. 1988

Collaborators

Detail Information

Publications11

  1. ncbi Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine
    Luigi Fiume
    Department of Experimental Pathology, University of Bologna, Via San Giacomo, 14 40126 Bologna, Italy
    J Hepatol 43:645-52. 2005
    ....
  2. ncbi Lactosaminated human albumin, a hepatotropic carrier of drugs
    Luigi Fiume
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, I 40126 Bologna, Italy
    Eur J Pharm Sci 40:253-62. 2010
    ....
  3. ncbi Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug
    Luigi Fiume
    Department of Experimental Pathology, University of Bologna, Italy
    Drug Discov Today 13:1002-9. 2008
    ..Unexpectedly, it was found that the conjugate enhanced DOXO concentrations in all forms of HCCs, independently of their differentiation grade...
  4. ncbi The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow
    L Fiume
    Department of Experimental Pathology, University of Bologna, Italy
    Eur J Pharm Biopharm 72:630-1. 2009
    ..This observation casts some doubts about the possibility that the value of anticancer agents with toxic side effects on liver and bone marrow can be improved by imatinib...
  5. ncbi Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy
    Dig Liver Dis 38:404-8. 2006
    ..If further studies will confirm the efficacy and safety of this compound, coupled doxorubicin therapy may open a new perspective in the treatment of hepatocellular carcinoma...
  6. ncbi Coupling of 5-fluoro 2'-deoxyuridine to lactosaminated poly-l-lysine: an approach to a regional, non-invasive chemotherapy of liver micrometastases
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, 40126, Bologna, Italy
    Biochem Pharmacol 61:459-65. 2001
    ..The drug released from hepatic cells into liver blood following conjugate administration via the peripheral venous route might accomplish a locoregional, non-invasive treatment of micrometastases nourished by liver sinusoids...
  7. ncbi Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Bologna, Italy
    Dig Liver Dis 40:278-84. 2008
    ..The aim of the present study was to investigate the effects of lactosaminated human albumin coupled doxorubicin on the growth of established rat hepatocellular carcinomas induced by diethylnitrosamine...
  8. ncbi Floxuridine coupling with lactosaminated human albumin to increase drug efficacy on liver micrometastases
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Italy
    Dig Liver Dis 34:439-46. 2002
    ....
  9. ncbi Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier
    G Di Stefano
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy
    Dig Liver Dis 35:428-33. 2003
    ....
  10. ncbi Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin
    L Fiume
    Department of Experimental Pathology, University of Bologna, Italy
    Lancet 2:13-5. 1988
    ..No antibodies (IgM and IgG classes) that bound the conjugate were detected. Thus L-HSA-ara-AMP inhibits HBV replication as well as free ara-AMP but at a third to a sixth of the dose...
  11. ncbi Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways
    F Farabegoli
    Department of Experimental Pathology, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy
    Eur J Pharm Sci 47:729-38. 2012
    ....